We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$582M
AUM Growth
+$6.88M
Cap. Flow
+$1.14M
Cap. Flow %
0.2%
Top 10 Hldgs %
40.49%
Holding
84
New
1
Increased
31
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
MTD icon
Mettler-Toledo International
MTD
+$1.11M
2
GWW icon
W.W. Grainger
GWW
+$749K
3
TIF
Tiffany & Co.
TIF
+$598K
4
STT icon
State Street
STT
+$556K
5
CGNX icon
Cognex
CGNX
+$537K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.85M
2
EWH icon
iShares MSCI Hong Kong ETF
EWH
+$1.25M
3
HON icon
Honeywell
HON
+$377K
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$293K
5
CAT icon
Caterpillar
CAT
+$272K

Sector Composition

Rank Sector Weight
1 Healthcare 30.43%
2 Technology 15.81%
3 Industrials 13%
4 Consumer Staples 10.84%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$32.6B
$36.7M 6.3%
119,857
-8,973
-7% -$2.85M
TIF
2
DELISTED
Tiffany & Co.
TIF
$31.5M 5.41%
365,779
+6,738
+2% +$598K
SSYS icon
3
Stratasys
SSYS
$701M
$25.6M 4.4%
241,629
+2,091
+0.9% +$250K
BF.B icon
4
Brown-Forman Class B
BF.B
$12.3B
$23.9M 4.11%
833,713
-7,421
-0.9% -$195K
JNJ icon
5
Johnson & Johnson
JNJ
$663B
$23.6M 4.05%
239,873
-1,062
-0.4% -$98.5K
SLB icon
6
SLB Ltd
SLB
$85.3B
$19.2M 3.31%
197,421
+1,166
+0.6% +$105K
GWW icon
7
W.W. Grainger
GWW
$62.4B
$19.2M 3.3%
76,010
+3,000
+4% +$749K
DHR icon
8
Danaher
DHR
$146B
$19.2M 3.3%
380,861
+5,938
+2% +$302K
NVO
9
Novo Nordisk
NVO
$206B
$18.7M 3.21%
818,380
+4,600
+0.6% +$98K
ADI icon
10
Analog Devices
ADI
$176B
$18M 3.09%
338,634
-3,834
-1% -$193K
CGNX icon
11
Cognex
CGNX
$10.5B
$17.8M 3.07%
1,053,770
+28,770
+3% +$537K
SYT
12
DELISTED
Syngenta Ag
SYT
$17.1M 2.93%
225,002
+3,695
+2% +$275K
HON icon
13
Honeywell
HON
$66.4B
$16.6M 2.85%
198,972
-4,558
-2% -$377K
NEOG icon
14
Neogen
NEOG
$2.58B
$16M 2.75%
948,552
+31,613
+3% +$517K
RTN
15
DELISTED
Raytheon Company
RTN
$15M 2.58%
152,209
-2,825
-2% -$268K
TRMB icon
16
Trimble
TRMB
$13.9B
$14.7M 2.52%
376,951
+10,271
+3% +$370K
KOF icon
17
Coca-Cola Femsa
KOF
$23.5B
$14M 2.41%
132,706
+3,131
+2% +$327K
HSIC icon
18
Henry Schein
HSIC
$10B
$13.5M 2.32%
288,295
-1,403
-0.5% -$64.1K
CTXS
19
DELISTED
Citrix Systems Inc
CTXS
$12.5M 2.15%
273,551
+11,300
+4% +$533K
AMGN icon
20
Amgen
AMGN
$236B
$12.4M 2.13%
100,398
-1,275
-1% -$155K
GE icon
21
GE Aerospace
GE
$350B
$11.5M 1.97%
92,492
-26
-0% -$3.21K
IDXX icon
22
Idexx Laboratories
IDXX
$42.2B
$11.4M 1.95%
187,330
+300
+0.2% +$17.9K
WSM icon
23
Williams-Sonoma
WSM
$26.8B
$10.1M 1.73%
302,760
+16,180
+6% +$471K
OXY icon
24
Occidental Petroleum
OXY
$60B
$9.76M 1.68%
106,945
-219
-0.2% -$19.6K
FEZ icon
25
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.47B
$9.15M 1.57%
214,416
+5,771
+3% +$239K
1
2 3 4

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q1 2014 Portfolio in Review

As of Q1 2014, Tirschwell & Loewy held 84 positions worth $582M, up 1.2% from $575M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tirschwell & Loewy's Q1 2014 filing shows 1 new, 31 increased, 32 reduced and 4 closed positions. The largest sale was Biogen, an estimated $2.85M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy added most to Mettler-Toledo International in Q1 2014, an estimated $1.11M increase.
  • Tirschwell & Loewy's biggest Q1 2014 reduction was Biogen, cutting an estimated $2.85M.
  • Tirschwell & Loewy fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $293K.
  • Tirschwell & Loewy's ten largest holdings make up 40% of its $582M portfolio in Q1 2014.
  • Tirschwell & Loewy opened 1 new position and closed 4 in Q1 2014.
  • Tirschwell & Loewy's portfolio value rose 1.2% quarter-over-quarter to $582M.

Based on Tirschwell & Loewy's 13F filing for Q1 2014, filed 1 May 2014.